Target intelligence / Profile preview

MicroRNA regulating bone metabolism (miRNA)

Target
miRNA
Molecular classification
Other, non-coding RNA, microRNA
01

Overview

MicroRNAs (miRNAs) regulating bone metabolism constitute a large and functionally diverse group of small (~22 nucleotide) non-coding RNAs that modulate gene expression at the post-transcriptional level. They play critical roles in bone development, remodeling, and homeostasis by influencing processes such as osteoblast and osteoclast differentiation, bone matrix formation, and bone resorption through the regulation of mRNA translation and degradation. Individual miRNAs (e.g., miR-21, miR-155, miR-133a, miR-214, miR-206) target distinct genes and signaling pathways central to bone cell function and skeletal disease. The field is of high translational interest, but the term "microRNA regulating bone metabolism" encompasses a class of molecules rather than a specific druggable target, complicating both therapeutic development and structured data extraction[1][2][3][4][5].

Other names
Bone metabolism-related microRNAbone-regulating microRNAosteogenic microRNAbone metabolism miRNAmiRNAs in bone biologymicroRNA in skeletal remodeling
02

Mechanism of action

Antagomirs (antisense oligonucleotides inhibiting specific miRNAs); miRNA mimics (restoring functional levels of deficient miRNAs); Modulation of miRNA activity through exosome delivery or gene editing

03

Biological functions

Regulation of osteoblast and osteoclast differentiationBone formation and resorptionEpigenetic regulation of gene expressionCell proliferation and apoptosis in bone tissueModulation of key signaling pathways (e.g., Wnt/β-catenin, TGF-β/BMP, Notch)
04

Disease associations

OsteoporosisOther bone metabolic diseasesPotential roles in cancer (bone metastasis), inflammation, and other conditions involving bone remodeling
05

Safety considerations

Off-target effects due to broad regulatory roles of miRNAsPotential disturbance of global gene regulatory networksLimited tissue specificity, pharmacokinetic challenges, and immune reactions
06

Biomarkers

Several bone-specific miRNAs proposed as potential biomarkers for diagnosis, prognosis, or treatment response in osteoporosis and bone metabolic disorders

Beyond the preview

Go deeper on MicroRNA regulating bone metabolism (miRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA regulating bone metabolism (miRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call